FOXA1 and urinary bladder cancer: Using isogenic bladder cancer cells in which FOXA1 was genetically ablated using CRISPR/Cas9, we were able to show that loss of FOXA1 expression was sufficient to induce PD-L1 expression in bladder cancer cells.